Why Moderna Might Be a One-Hit Wonder
Can you believe that Moderna (NASDAQ: MRNA) was once worth more than $195 billion in 2021? Back then, the business looked on track to be the next big healthcare company.
Then, demand for its COVID-19 vaccine started to diminish. As hospitals resumed normal operations and anti-vaccine sentiment grew, there wasn't nearly as much demand for COVID-19 shots anymore. While Moderna still generates revenue from its vaccine, it's just a fraction of what it was in 2021.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
Currently there is a rather negative sentiment for Moderna Inc. with 7 Buy predictions and 10 Sell predictions..
This results in a negative potential of -26.31% based on a current price of 29.86 € and a target price of 22 € for the stock.


